Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.